Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus
Clinical trial NCT06789107 · RECRUITING
Trial details
- NCT number
- NCT06789107
- Sponsor
- Mao Jianhua
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-08
- Primary completion
- 2027-12-07
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.